Gambaran Umum
Ardelyx, Inc. is a biopharaceutical company based in the United States, specifically headquartered in Fremont, California. The company operates primarily within the healthcare sector with a focus on innovating and developing first-in-class medicines for the treatment of renal and gastrointestinal diseases. Ardelyx's key projects include the development of tenapanor, which is a pioneering treatment designed to manage hyperphosphatemia in patients with chronic kidney disease on dialysis. This proprietary drug directly targets the issue of elevated phosphate levels looking to improve patient outcomes significantly. The company is also actively involved in advancing a pipeline of other novel compounds that address similar conditions in underserved patient populations, demonstrating Ardelyx’s commitment to addressing complex clinical challenges through targeted therapies.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Ardelyx, Inc. per 2025 Jun 30 adalah 386.15 MM.
- Nilai operating income untuk Ardelyx, Inc. per 2025 Jun 30 adalah -40.39 MM.
- Nilai net income untuk Ardelyx, Inc. per 2025 Jun 30 adalah -56.39 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 386.15 | -40.39 | -56.39 |
2025-03-31 | 361.71 | -39.62 | -53.76 |
2024-12-31 | 333.62 | -27.95 | -39.14 |
2024-09-30 | 251.85 | -64.06 | -72.58 |
2024-06-30 | 210.00 | -58.90 | -65.14 |
2024-03-31 | 159.11 | -61.89 | -65.81 |
2023-12-31 | 124.46 | -63.28 | -66.07 |
2023-09-30 | 134.27 | -23.15 | -26.57 |
2023-06-30 | 82.87 | -52.42 | -56.09 |
2023-03-31 | 63.06 | -62.02 | -65.91 |
2022-12-31 | 52.16 | -63.76 | -67.21 |
2022-09-30 | 9.01 | -114.78 | -114.14 |
2022-06-30 | 5.20 | -131.53 | -134.83 |
2022-03-31 | 3.98 | -150.15 | -153.08 |
2021-12-31 | 10.10 | -148.15 | -158.16 |
2021-09-30 | 10.88 | -143.12 | -150.81 |
2021-06-30 | 12.42 | -121.64 | -125.33 |
2021-03-31 | 12.94 | -101.02 | -105.09 |
2020-12-31 | 7.57 | -90.78 | -94.31 |
2020-09-30 | 8.01 | -81.98 | -85.23 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | -0.17 | |
2024-09-30 | -0.31 | -0.32 |
2024-06-30 | -0.28 | -0.28 |
2024-03-31 | -0.29 | -0.29 |
2023-12-31 | -0.30 | |
2023-09-30 | -0.13 | -0.12 |
2023-06-30 | -0.29 | -0.28 |
2023-03-31 | -0.37 | -0.37 |
2022-12-31 | -0.42 | |
2022-09-30 | -0.82 | -0.82 |
2022-06-30 | -1.09 | -1.09 |
2022-03-31 | -1.36 | -1.36 |
2021-12-31 | -1.52 | -1.52 |
2021-09-30 | -1.54 | -1.53 |
2021-06-30 | -1.33 | -1.32 |
2021-03-31 | -1.15 | -1.14 |
2020-12-31 | -1.05 | -1.05 |
2020-09-30 | -1.01 | -1.01 |
2020-06-30 | -1.17 | -1.17 |
2020-03-31 | -1.28 | -1.28 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Ardelyx, Inc. per 2025 Jun 30 adalah -53.49 MM.
- Nilai cash from investing activities untuk Ardelyx, Inc. per 2025 Jun 30 adalah -1.50 MM.
- Nilai kas dari aktivitas pendanaan untuk Ardelyx, Inc. per 2025 Jun 30 adalah 103.15 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -53.49 | -1.50 | 103.15 |
2025-03-31 | -47.54 | -12.89 | 55.10 |
2024-12-31 | -44.81 | -18.32 | 106.59 |
2024-09-30 | -63.34 | -6.26 | 83.26 |
2024-06-30 | -85.31 | -41.30 | 138.44 |
2024-03-31 | -80.64 | -124.04 | 148.35 |
2023-12-31 | -89.72 | -131.25 | 146.29 |
2023-09-30 | -66.72 | -100.24 | 139.09 |
2023-06-30 | -70.67 | -68.38 | 115.70 |
2023-03-31 | -87.22 | 6.31 | 126.32 |
2022-12-31 | -70.04 | 18.41 | 75.34 |
2022-09-30 | -123.80 | 39.07 | 71.07 |
2022-06-30 | -132.96 | 58.03 | 41.59 |
2022-03-31 | -135.95 | 50.80 | 48.17 |
2021-12-31 | -152.55 | 50.95 | 83.00 |
2021-09-30 | -130.67 | 25.28 | 89.67 |
2021-06-30 | -115.96 | 16.74 | 85.47 |
2021-03-31 | -100.71 | 21.93 | 56.95 |
2020-12-31 | -81.44 | -31.44 | 22.78 |
2020-09-30 | -74.98 | -83.33 | 156.65 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Efektivitas Manajemen
- roe untuk Ardelyx, Inc. pada 2025 Jun 30 adalah -0.51.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.51 | ||||
2025-03-31 | -0.51 | ||||
2024-12-31 | -0.51 | ||||
2024-09-30 | -0.51 | ||||
2024-06-30 | -0.51 | ||||
2024-03-31 | -0.51 | ||||
2023-12-31 | -0.51 | ||||
2023-09-30 | -0.51 | ||||
2023-06-30 | -0.51 | ||||
2023-03-31 | -0.51 | ||||
2022-12-31 | -0.51 | ||||
2022-09-30 | -0.51 | ||||
2022-06-30 | -0.51 | ||||
2022-03-31 | -0.51 | ||||
2021-12-31 | -0.51 | ||||
2021-09-30 | -0.51 | ||||
2021-06-30 | -0.51 | ||||
2021-03-31 | -0.51 | ||||
2020-12-31 | -0.36 | -0.51 | -0.53 | -0.50 | -0.45 |
2020-09-30 | -0.71 | -1.73 | -0.43 | -0.01 | -0.38 |
2020-06-30 | -0.66 | -1.32 | -0.45 | 0.05 | -0.38 |
2020-03-31 | -0.55 | -0.99 | -0.41 | 0.06 | -0.38 |
Gross Margins
- marjin bersih untuk Ardelyx, Inc. pada 2025 Jun 30 adalah -12.46.
- marjin operasi untuk Ardelyx, Inc. pada 2025 Jun 30 adalah -11.99.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | -12.46 | -11.99 | |
2025-03-31 | -12.46 | -11.99 | |
2024-12-31 | -12.46 | -11.99 | |
2024-09-30 | -12.46 | -11.99 | |
2024-06-30 | -12.46 | -11.99 | |
2024-03-31 | -12.46 | -11.99 | |
2023-12-31 | -12.46 | -11.99 | |
2023-09-30 | -12.46 | -11.99 | |
2023-06-30 | -12.46 | -11.99 | |
2023-03-31 | -12.46 | -11.99 | |
2022-12-31 | -12.46 | -11.99 | |
2022-09-30 | -12.46 | -11.99 | |
2022-06-30 | -12.46 | -11.99 | |
2022-03-31 | -12.46 | -11.99 | |
2021-12-31 | -12.46 | -11.99 | |
2021-09-30 | -12.46 | -11.99 | |
2021-06-30 | -12.46 | -11.99 | |
2021-03-31 | -12.46 | -11.99 | |
2020-12-31 | -7.61 | -12.46 | -11.99 |
2020-09-30 | 2.29 | -10.64 | -10.23 |
2020-06-30 | 1.53 | -10.91 | -10.46 |
2020-03-31 | 1.61 | -14.04 | -13.48 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1437402 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |